Filtering options
Advanced Analytics
Advanced Therapies
Biologics
Biometrics
Biopharma
BioRegion
Biostatistics
Biotech
Cardiology
CDD
CDMO
Clinical
Clinical Operations
Clinical Trials
CMC
Co-Design
Complex Innovative Design
CRO
Crowdfunding
Data Science
Decentralized Clinical Trials
Dermatology
Diabetes
Diagnostics
Digital Health
Digital Therapeutics
Digital Transformation
Diversity
Drug Development
Due Diligence
eCOA
Economic Policy
Environmental Policy
EU
European Medicines Agency
France
Funding
Genomic Testing
Health Economics
Health Policy
Healthcare Technology
HEOR
Hybrid Clinical Trials
In-Vitro Diagnostic Regulation
Innovation
Investor Relations
ISE/ISS
Italy
IVDR
Life Sciences
Lifecycle Optimization
Lupus
M&A
Market Access
Medical Devices
Medical Robotics
MedTech
Mobile Tech
Oncology
Orphan Drug
Outcomes Research
Outsourcing Clinical Trials
Patient Advocacy
Patient Centricity
Patient Engagement
Pharma
Press Release
Product Development
Rare Disease
Real-World Evidence (RWE)
Registry-based studies
Regulatory
Research & Development
Research and Development
RWE Decision Alert
Spain
Startups
Therapeutics
Transaction Advisory
UK
USA
Vaccines
Wound Healing
All
Multimedia
Latest from Alira Health
Technological Innovations in Diabetes Management Medical Devices
Discover the notable trends in the diabetes management devices market including glucose monitoring, insulin delivery and digital health.
Misconceptions About Patient-Centric Co-Design
Many people have misconceptions about patient-centric co-design, and these misconceptions are holding companies back.
Natural Language Processing for Analysis of Complex Diseases in the Hospital Setting (Lupus Case)
A hospital-specific NLP-powered platform can identify and characterize patients to provide pharma and biotech companies with fit-for-purpose RWD.
Pharma Develops e-Health Solution That Prioritizes Patients’ True Unmet Needs
A leading pharma company in the respiratory market sought support developing the right digital platform to expand their patient base and increase retention.
Bayesian Trial Design to Generate Evidence of the Safety and Efficacy of a Drug Regimen
A biotech company sought support in the design of their Phase II clinical trial to test the safety and efficacy of a novel inhibitor in combination with Pembrolizumab in patients with(...)
Leveraging a Virtual Site to Boost Diversity and Enrollment
The client’s study aimed to assess the sensitivity and specificity of a novel diagnostic test for colorectal cancer in a large population representative of the diversity in the US.
ACR Convergence 2023
We are pleased to announce that we will be joining ACR Convergence 2023, the world’s premier rheumatology event.
Spain Healthcare Innovation Summit
We will sponsor and speak at Spain Healthcare Innovation Summit, a premier event that brings together healthcare professionals from across Spain and beyond to discuss the latest developments(...)
Virtual Startup Demo Day
Join us and hear pitches from the leading startups in New England and beyond at the MassMedic Startup Virtual Demo Day.
Alira Health to Present at the Piper Sandler 35th Annual Healthcare Conference
Alira Health announced that Gabriele Brambilla, Alira Health’s Chief Executive Officer and Co-Founder, and Piergiulio Lauriano, Chief Strategy Officer at Alira Health, will present(...)
Alira Health and FORWARD Launch Enhanced Lupus Patient Registry, Accelerating Solutions for Patients
Alira Health and FORWARD announced the launch of the enhanced Lupus Registry, enabling patients, caregivers, and research sponsors to gain better insights, and achieve better patient outcomes.
Alira Health Partners with the Patient Empowerment Network Enabling Cancer Patients to Take Control of their Health and Treatment
Alira Health and the Patient Empowerment Network announced their partnership in supporting those impacted by cancer with a mobile platform delivering essential support for their medical needs.
SOHONOS, the First Drug for Fibrodysplasia Ossificans Progressiva, Receives US FDA Approval with Real-World Evidence as External Control
SOHONOS, the first drug for fibrodysplasia ossificans progressiva, receives US FDA approval with Real-World Evidence as external control
Therapeutic IgG-Like Bispecific Antibodies: Modular Versatility and Manufacturing Challenges
Our experts conducted a deep evaluation of IgG-like bsAbs including general advantages and disadvantages compared with MAbs and more.
Immunoglobulin Fc-Fusion Proteins
Our experts published a series of articles in BioProcess International reviewing the state of the art of Fc – fusion proteins, including their structure and molecular design, manufacturing(...)
Subscribe to our newsletter for the latest news, events, and thought leadership